Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Masters of Scale
00:00
Intro
This chapter explores the difficulties faced by a new pharmaceutical initiative striving to transform drug pricing and enhance accessibility. It details the competitive barriers set by established companies and includes a pivotal meeting with a key industry figure that highlights the complexities of entrepreneurial collaboration.
Transcript
Play full episode
